Latest filing published 08 Jun 2018 for HAEMONETICS CORP, €14k.
Filing timeline
BuySaleInsider track record
Neil Ryding: trading record in brief
This profile gathers the share dealings of Neil Ryding in Haemonetics Corp. In total, 5 filings cover trades dated from 20 October 2016 to 7 June 2018.
Sales make up the whole of the open-market record (4 sales, €49k). Besides market trades, the filings include 1 share grant. 2018 to date brings no purchases and 4 sales.
The latest filing, published on 8 June 2018, reports an open-market sale of €14k in Haemonetics Corp. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Neil Ryding
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 183 shares@ US$92.7337.6% of flowCommon StockSEC:0001127602-18-020492:0
- 351 shares@ US$34.16Common StockSEC:0001127602-18-018570:0
- 3,303 shares@ US$40.32Common StockSEC:0001127602-18-018570:1
- 346 shares@ US$45.7034.9% of flowCommon StockSEC:0001127602-18-018570:2
- 267 shares@ US$46.7627.6% of flowCommon StockSEC:0001127602-18-018570:3
5 of 5 declarations
